Skip to Main Content

STAT announces 46 inaugural STATUS List honorees

For Immediate Release: February 22, 2022 Media Contact: Maria Landron | [email protected] The STATUS List is the most definitive accounting of important and impactful individuals in health, medicine, and science With the premiere of “Augmented,” a bevy of notable hires, and now the STATUS List, STAT continues to expand its reach and influence BOSTON — STAT,…

How to train a clinical AI to predict bad health outcomes

In the latest edition of STAT Health Tech: how to train your AI to predict bad outcomes, the ripple effects of privacy laws, and digital health's notable leaders.

Anne Wojcicki

Wojcicki co-founded 23andMe 16 years ago, and although the company is best known for its low-cost consumer genetic testing service, it works on a variety of health care and biotechnology fronts. A test for prostate cancer risk won FDA clearance this January. 23andMe has recently launched, in partnership with GSK, a clinical trial for an…

Pharmalittle: Pfizer pill reduced deaths in newly diagnosed Covid patients; U.S. cancels contract with Emergent

An experimental antiviral pill developed by Pfizer reduced the risk of death and hospitalization by 89% in patients who were newly diagnosed with Covid-19.

3 pressing questions on 23andMe’s pivot into primary care

“What are the chances 23andMe is going to be one of the last-standing, dominant players in telemedicine? I would say the chances are very low.”

Noom steps into mental health, Big Health inks a big deal, & a new virtual care startup on the block

In the latest edition of STAT Health Tech: Noom steps into mental health, Big Health inks a big deal, & a new virtual care startup on the block.

A new startup ventures to make its mark in the virtual primary care market

Marley Medical launched Thursday with a promise to treat chronic conditions with an array of remote services and a team-based approach.

Lyra tackles alcohol use disorder and other mental health conditions

Lyra, the mental health startup that’s piled up a $4.6 billion valuation, announced a new slate of offerings tackling serious mental health conditions.

A slice of Apple’s health research, Teladoc for Teams, & combating health misinfo

Apple is gearing up to release a new metric called Walking Steadiness aimed at preventing falls in older people, but so far, the company has only shared a narrow glimpse of studies underpinning the tool.

STAT Announces Inaugural Breakthrough Science Summit to Explore Cutting-Edge Innovations in Health Care

This year’s Summit will feature expert voices from the FDA, leading pharmaceutical companies and other industry stakeholders BOSTON, MA – STAT, the nation’s must-read health, science, and medicine publication, recently announced that its inaugural 2021 STAT Breakthrough Science Summit will take place July 13-14. After a year that forced to innovation at unprecedented speed, the…

5 startups seizing the moment to shake up the electronic health record industry

“Savvy consumers really want a better system than what we have,” said Lucia Savage, chief privacy officer of Omada Health.

With $12 million in new funding, data-syncing platform Seqster takes aim at health records

The data-syncing platform lets patients combine health information from electronic health records, wearables, and DNA sequencing platforms.

2021 STAT Breakthrough Science Summit

View Highlights About Come here for the cutting edge Technologies and procedures that would have been science fiction are now the reality of medicine. Our 2021 STAT Breakthrough Science Summit took attendees inside these innovations, examining how they're being developed, adopted, and paid for. We also explored the breakthroughs that haven't yet hit the market,…

5 burning questions on the business of big genetics based on 23andMe’s filing to go public

When will 23andMe turn a profit? And how central will drug development become to its business?

The Pajama Interview: A conversation with Anne Wojcicki and Richard Branson

The Pajama Interview: A conversation with 23andMe's Anne Wojcicki and Virgin's Richard Branson.

23andMe to go public via Richard Branson’s SPAC

"In my opinion, there's no better way to invest your money than in health care," said Richard Branson.

Leading genetics experts call for more racial representation in their industry

“Diversity’s literally in our DNA, because there’s no way I’m doing a study that’s just European folks because I want it to apply to everybody,” TruGenomix's Tshaka Cunningham said.

23andMe’s next challenge: ensuring its customers can get drugs developed with their data

23andMe CEO Anne Wojcicki wants customers to “feel proud” if a drug developed with their data reaches the market, but the company still has to figure out how to ensure they have access to these medicines.

A landmark for STAT

Today marks a milestone for us at STAT. We published the 2,000th First Opinion, our forum for perspectives and personal stories about health, medicine, and science.

STAT+ Conversations: 23andMe CEO says spit kit sales are picking up during the Covid-19 pandemic

"Frankly, we were actually quite surprised that sales rebounded quite a bit from March," @23andMe CEO Anne Wojcicki told STAT.

Hospital CEOs, med school leaders shouldn’t sit on for-profit health care company boards

Hospital CEOs and academic leaders at the level of deans and presidents should devote their full attention to their day jobs and defer positions on the boards of for-profit companies to the post-leadership phase of their careers.

Cancer drug is the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration

The effort to validate drugs with 23andMe's vast genetic database is “exceeding, I think, everyone’s expectations,” said Hal Barron, GlaxoSmithKline’s chief scientific officer.

STAT Summit 2020

Nov 16-19Online#statsummit About The 2020 STAT Summit: What’s next? The coronavirus pandemic has reset our expectations of what is possible. New medicines and vaccines are being developed at a previously unimaginable pace. Telemedicine has replaced the doctor’s office. Now, we’re starting to figure out how the world has been reshaped in the wake of Covid-19,…

23andMe says it’s ‘part of the problem’ on racial inequity. We asked geneticists what the company can do about it

23andMe says it’s ‘part of the problem’ on racial inequity. STAT asked geneticists and health disparities experts what the company and its competitors can do about it.

STAT Health Tech Summit 2020

About The STAT Health Tech Summit is complete And that’s a wrap! Thanks to all who helped make this first virtual Summit so special. If you weren’t able to join us, you can read all of the event coverage. Where health tech meets biotech Breakthroughs in health and medicine are not just biological — they’re…

23andMe laying off 14% of employees amid slump in DNA spit kit sales

In the latest sign of a slump in consumer genetic testing, 23andMe is laying off 14% of its workforce amid falling sales of its DNA spit kits.

An AI startup, led by 23andMe veteran Andy Page, tries to take better pictures of the heart

Can artificial intelligence “democratize” the use of the heart ultrasound?

As more dogs are tested for potential genetic diseases, experts say use caution

Dog owners may want genetic screening for their dogs, but several veterinarians and scientists say companies too often provide misleading results.